| Bioactivity | SARS-CoV-2-IN-84 (compound 20) is aSARS-CoV-2 inhibitor that targets the 3CL protease (3CL Pro) of SARS-CoV-2 (IC50: 369.5 nM ).[2][1]. |
| Target | IC50: 369.5 nM (3CL protease of SARS-CoV-2) |
| CAS | 214221-82-6 |
| Formula | C16H13BrO4 |
| Molar Mass | 349.18 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gu Z, et al. Discovery of Covalent Lead Compounds Targeting 3CL Protease with a Lateral Interactions Spiking Neural Network. J Chem Inf Model. 2024 Apr 22;64(8):3047-3058. |
SARS-CoV-2-IN-84
CAS: 214221-82-6 F: C16H13BrO4 W: 349.18
SARS-CoV-2-IN-84 (compound 20) is aSARS-CoV-2 inhibitor that targets the 3CL protease (3CL Pro) of SARS-CoV-2 (IC50: 369
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.